Coronavirus main protease (Mpro) inhibitor (respective IC50 values are 2.7, 4 and 8.8 μM for MHV-A29, HCoV-229E and FOPV replication in vitro). Inhibits viral cell infection in an MHV plaque reduction assay. Also inhibits SARS-CoV-2 viral cell entry in a plaque reduction assay (IC50 = 16.8 μM).

884650-98-0

C35H48N6O8

680.79

MPro N3

DMSO:34.04 mg/mL(50 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years